In yesterday’s Wall Street session, Alkermes plc (NASDAQ:ALKS) shares traded at $29.65, up 0.51% from the previous session.
ALKS stock price is now 2.88% away from the 50-day moving average and 11.15% away from the 200-day moving average. The market capitalization of the company currently stands at $4.80B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target enhanced from $25 to $36, Stifel Upgraded its rating from Hold to Buy for Alkermes plc (NASDAQ: ALKS). On June 17, 2024, TD Cowen recently initiated its ‘Buy’ rating on the stock quoting a target price of $34, while ‘Robert W. Baird’ rates the stock as ‘Outperform’
In other news, Hopkinson Craig C., EVP R&D, Chief Medical Officer sold 61,151 shares of the company’s stock on Dec 09 ’24. The stock was sold for $1,961,406 at an average price of $32.07. Upon completion of the transaction, the EVP R&D, Chief Medical Officer now directly owns 47,576 shares in the company, valued at $1.41 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 09 ’24, Director LAURENCIN CATO T sold 2,691 shares of the business’s stock. A total of $85,708 was realized by selling the stock at an average price of $31.85. This leaves the insider owning 23,013 shares of the company worth $0.68 million. A total of 1.86% of the company’s stock is owned by insiders.
During the past 12 months, Alkermes plc has had a low of $22.90 and a high of $32.88. As of last week, the company has a debt-to-equity ratio of 0.28, a current ratio of 3.45, and a quick ratio of 3.03. According to the stock market information, the enterprise value for the company is $4264291584, which is based on a 15.10 price-to-earnings ratio, a 1.13 price-to-earnings-growth ratio, and a beta of 0.49. The fifty day moving average price for ALKS is $28.8084 and a two-hundred day moving average price translates $26.67075 for the stock.
The latest earnings results from Alkermes plc (NASDAQ: ALKS) was released for 2024-09-30. The net profit margin was 22.15% and return on equity was 29.23% for ALKS. The company reported revenue of $378.14 million for the quarter, compared to $380.94 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -0.73 percent. For the current quarter, analysts expect ALKS to generate $380.74M in revenue.
